Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Total article views   HTML views PDF downloads Totals
7,222 Dovepress* 7,222+ 1,878 9,100
Totals 7,222 1,878 9,100
*Since 15 March 2007
+Since July 2016

View citations on Google Scholar